Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
CerSci Therapeutics
3212
CerSci Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
CerSci Therapeutics is a clinical-stage biotechnology company developing non-opioid pharmaceuticals for the treatment of pain.
Suggest edits
Founded
2015
Raised
$1.9M
Follow us
Also headquartered in Dallas
AT&T
Ryan
Southwest Airlines
MoneyGram
Mark Cuban
Cyber Group
Match
Hedera Hashgraph
Glass
Energy Transfer Partners
Companies in the same industry
EnClear Therapies
Immunai
Stemson Therapeutics
Moderna Therapeutics
miRagen Therapeutics
Adagene
NeuroTherapia, Inc.
Motus Therapeutics
CureVac AG
Nohla Therapeutics
Alexa global traffic share
Overview
Funding
2
Add info
Acquired by
1
25 Aug 2020
ACADIA Pharmaceuticals Inc.
$52,500,000
Latest funding
$1,650,000
Grant - 2017
National Institute on Drug Abuse (NIDA)
$225,000
Grant - 2017
National Institutes of Health
Location
Dallas
,
United States
Headquarters
Explore Dallas
FinSMEs
Acadia Pharmaceuticals Acquires CerSci Therapeutics
$52,500,000
Xconomy
Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout
$1,650,000
Grant
D Magazine
UT Dallas Startup Develops Technology to Battle Opioid Epidemic
$225,000
Grant
texastechpulse
CerSci Therapeutics Finds $225,000 From SBIR Grant
